MNOV
MediciNova Inc
2.60$
-2.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 77.8% | 77.2% | 76.1% | 75.3% | 74.4% | 73.5% | 71.9% | 70.5% | 69.2% | 68.0% | 65.9% | 64.1% | |
| 75.6% | 77.0% | 74.9% | 73.4% | 72.7% | 72.2% | 69.8% | 68.8% | 68.4% | 67.6% | 64.0% | 62.9% | |
| 75.6% | 77.0% | 74.9% | 73.4% | 72.7% | 72.2% | 69.8% | 68.8% | 68.4% | 67.6% | 64.0% | 62.9% | |
| 1.5% | – | – | – | – | – | – | 0.3% | – | – | 0.6% | – | |
| 0.0% | – | – | – | – | – | – | – | – | – | – | – | |
| 14.1% | 14.5% | 15.3% | 15.9% | 16.5% | 17.2% | 18.3% | 19.3% | 20.2% | 21.1% | 22.5% | 23.7% | |
| 7.0% | 7.2% | 7.6% | 7.9% | 8.3% | 8.6% | 9.2% | 9.6% | 10.1% | 10.5% | 11.2% | 11.9% | |
| 5.1% | 5.9% | 4.9% | 5.0% | 5.3% | 6.0% | 4.8% | 6.0% | 7.6% | 8.8% | 7.7% | 7.8% | |
| 4.1% | 4.9% | 4.0% | 4.1% | 4.5% | 5.3% | 4.1% | 5.3% | 7.0% | 8.3% | 7.2% | 7.3% | |
| 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.3% | |
| 1.1% | 1.5% | 1.3% | 1.1% | 1.2% | 2.0% | 1.4% | 1.1% | 1.6% | 1.4% | 2.0% | 2.4% | |
| 94.9% | 94.1% | 95.1% | 95.0% | 94.7% | 94.0% | 95.2% | 94.0% | 92.4% | 91.2% | 92.3% | 92.2% | |
| -607.1% | -627.3% | -665.3% | -697.1% | -729.4% | -763.7% | -819.4% | -868.9% | -916.3% | -962.1% | -1,033.5% | -1,097.2% | |
| 72.0% | 74.0% | 78.0% | 81.2% | 84.4% | 87.8% | 93.5% | 98.4% | 103.1% | 107.6% | 115.3% | 121.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.